Рубен Николаевич

Business Unit Manager
с 05.2019 - (5 лет 7 месяцев)

Friesland Campina  (Киев)
Фармацевтическая промышленость

Responsibilities:

  National Sales Plan implementation

  Creation and development promotion strategy and tactic;

  SF team creation, training and supervision 

  Control of strategy implementation;

  KOLs and main DMs cooperation and development

  Involvement in global activities and exchange of experience

  Responsibility for tender segment

Achievements: 

  Formed and trained a new team in the Central and Eastern regions

  Strengthened the teams of the Western and Southern regions

  Created a promotion strategy and campaign book

  Formed a brand of products for the consumers

  Implemented the KPI's system to FF team

  Enlisted the support of main KOL's

  Friso Vom Comfort GR +20% in pcs (YTD 2019 vs 2020)

  1% sales increase on a falling market (YTD 2019 vs 2020)

  2021 YTD (Jan-Apr) GR 8% in kgs & GR 22% in UAH

Product marketing manager
с 10.2017 - по 01.2019 (1 год 3 месяца)

Ipsen Pharma  (Киев)
Фармацевтическая промышленость

Responsibilities:

  Creation and development of oncological products promotion strategy;

  Market analysis and evaluation; 

  Control of strategy implementation;

  SF team cooperation and support;

  KOLs and main DMs cooperation and development

  Cooperation with Patients organization

  Launch preparation and conduction

  Project and event management

  Involvement in global activities and exchange of experience

 Achievements: 

  Successful launch (TKI)

  Leading position of Somatuline in SSA segment (89% MS) 

  Leading position of Diphereline in LhRh segment (50% MS) 

  Somatuline GR +43% in EUR (2018 vs 2017)

  Diphereline GR + 31% in EUR (2018 vs 2017)

Product Manager
с 12.2016 - по 09.2017 ( 9 месяцев)

Биофарма  (Киев)
Фармацевтическая промышленость

Responsibilities:

  Creation and development of hospital products promotion strategy;

  Market analysis and evaluation; 

  Control of strategy implementation;

  SF team cooperation and support;

  KOLs and main DMs cooperation and development

  Cooperation with Patients organization

Achievements: 

  EI promo-group 141 % in UAH (Jan-Aug 2017)

  Leading position of Bioven in IVIG sub segment 

  Bioven GR 45% in UAH (Jan-Sep 2017/Jan-Sep 2016)

  Successful pharmacoeconomic justification for budgetary procurement (immunoglobulin Anti-D (Rh))

Medical representative
с 09.2009 - по 12.2016 (7 лет 3 месяца)

Берлин-Хеми  (Киев)
Фармацевтическая промышленость

Национальный медицинский университет им. А.А. Богомольца  (Киев )

Год окончания  2009

1-й лечебный